BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld
Home
» Genentech, Tanox Receive FDA Approval For Asthma Therapeutic
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Genentech, Tanox Receive FDA Approval For Asthma Therapeutic
June 23, 2003
By
Kim Coghill
No Comments
Genentech Inc. and partners Tanox Inc. and Novartis Pharma AG said late Friday the FDA approved Xolair, a first-in-class monoclonal antibody for moderate to severe persistent asthma in adults and adolescents. (BioWorld Today)
BioWorld